Cassava Sciences (NASDAQ: SAVA) furnishes new investor presentation

Rhea-AI Filing Summary

Cassava Sciences, Inc. filed a current report to furnish its latest corporate presentation under Regulation FD. The presentation, dated September 2025, is made available as Exhibit 99.1 and is also posted in the Investors section of the company’s website. The company states that this material is being furnished rather than filed, meaning it is not subject to certain liability provisions of the Exchange Act and will not be automatically incorporated into other securities law filings.

false 0001069530 0001069530 2025-09-08 2025-09-08

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 8, 2025

Cassava Sciences, Inc.

(Exact name of registrant as specified in its charter)

Delaware	001-41905	91-1911336
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

6801 N Capital of Texas Highway, Building 1; Suite 300

Austin, Texas 78731

(Address of principal executive offices, including zip code)

(512) 501-2444

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))
☐	Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value		SAVA		Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure

A copy of the Cassava Sciences, Inc. corporate presentation, which is posted in the “Investors” section of the Company’s website at www.CassavaSciences.com, is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

The information provided in this Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in such filing.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.		Description
99.1		Cassava Sciences, Inc. Corporate Presentation, dated September 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CASSAVA SCIENCES, INC.
	a Delaware corporation
Date: September 8, 2025
	By:	/s/  Eric J. Schoen
		Eric J. Schoen
		Chief Financial Officer

FAQ

What did Cassava Sciences (SAVA) disclose in this 8-K?

Cassava Sciences furnished a corporate presentation under Regulation FD, attaching it as Exhibit 99.1 and posting it in the Investors section of its website.

Is the Cassava Sciences corporate presentation considered filed with the SEC?

No. The company states the information in the 8-K, including Exhibit 99.1, is being furnished and shall not be deemed filed for purposes of Section 18 of the Exchange Act.

Where can investors access Cassava Sciences’ September 2025 presentation?

The presentation is attached as Exhibit 99.1 to the report and is posted in the “Investors” section of www.CassavaSciences.com.

What is the date of the Cassava Sciences corporate presentation?

The corporate presentation attached as Exhibit 99.1 is dated September 2025.

On which exchange is Cassava Sciences’ common stock listed?

Cassava Sciences’ common stock, par value $0.001, trades under the symbol SAVA on the Nasdaq Capital Market.

Who signed the Cassava Sciences 8-K related to the corporate presentation?

The report was signed on behalf of Cassava Sciences, Inc. by Eric J. Schoen, the company’s Chief Financial Officer.